Efficacy and Safety Study of the Oral Direct Thrombin Inhibitor H 367/95 Compared with Dose-Adjusted Warfarin (Coumadin) in the Prevention of Stroke and Systemic Embolic Events in Patients with Atrial Fibrillation (SPORTIF V) Protocol #233 (SH-TPA-0005)